Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose optimization of ropivacaine infiltration and gabapentin in total knee arthroplasty
NL-OMON39330Phase 2Active, not recruiting
- Sponsor
- Reinier de Graaf Hospital
- Start
- Sep 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of ropivacaine, gabapentin and epinephrine in postoperative pain (4 arms), sponsored by Reinier de Graaf Hospital. Primary endpoints: Pain score at day 1 and until discharge, Adverse effects and 3 more. Started Sep 2013; status: active, not recruiting.
02
Drugs
ropivacainegabapentinepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON39330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39330.